The future of the HBM4EU initiative is promising, with potential expansions to include more countries and chemicals. As technology advances, more sensitive and accurate methods of detection will become available, allowing for the assessment of lower concentrations and a broader range of substances. Additionally, integrating omics technologies with biomonitoring could provide deeper insights into the mechanisms of chemical toxicity and individual susceptibility. This progress will enable more precise risk assessments and enhance our ability to protect human health.
